340 related articles for article (PubMed ID: 30276516)
1. Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw.
Zirk M; Wenzel C; Buller J; Zöller JE; Zinser M; Peters F
Clin Oral Investig; 2019 May; 23(5):2143-2151. PubMed ID: 30276516
[TBL] [Abstract][Full Text] [Related]
2. Oral Abundance of Actinomyces spp. in Breast Cancer Patients.
Bilgilier C; Fuereder T; Kastner MT; Vass Z; Brandl I; Sahbegovic H; Singer CF; Steininger C
Oncology; 2022; 100(4):221-227. PubMed ID: 35051923
[TBL] [Abstract][Full Text] [Related]
3. The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection.
Russmueller G; Seemann R; Weiss K; Stadler V; Speiss M; Perisanidis C; Fuereder T; Willinger B; Sulzbacher I; Steininger C
Sci Rep; 2016 Aug; 6():31604. PubMed ID: 27530150
[TBL] [Abstract][Full Text] [Related]
4. The impact of surgical intervention and antibiotics on MRONJ stage II and III - Retrospective study.
Zirk M; Kreppel M; Buller J; Pristup J; Peters F; Dreiseidler T; Zinser M; Zöller JE
J Craniomaxillofac Surg; 2017 Aug; 45(8):1183-1189. PubMed ID: 28684074
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid.
Wei LY; Kok SH; Lee YC; Chiu WY; Wang JJ; Cheng SJ; Chang HH; Lee JJ
J Formos Med Assoc; 2021 Aug; 120(8):1572-1580. PubMed ID: 33309430
[TBL] [Abstract][Full Text] [Related]
6. Actinomyces and MRONJ: A retrospective study and a literature review.
Cerrato A; Zanette G; Boccuto M; Angelini A; Valente M; Bacci C
J Stomatol Oral Maxillofac Surg; 2021 Nov; 122(5):499-504. PubMed ID: 32827811
[TBL] [Abstract][Full Text] [Related]
7. Influence of induced infection in medication-related osteonecrosis of the jaw development after tooth extraction: A study in rats.
Bolette A; Lecloux G; Rompen E; Albert A; Kerckhofs G; Lambert F
J Craniomaxillofac Surg; 2019 Feb; 47(2):349-356. PubMed ID: 30595476
[TBL] [Abstract][Full Text] [Related]
8. Role of microbiological culture and polymerase chain reaction (PCR) of actinomyces in medication-related osteonecrosis of the jaw (MRONJ).
Panya S; Fliefel R; Probst F; Tröltzsch M; Ehrenfeld M; Schubert S; Otto S
J Craniomaxillofac Surg; 2017 Mar; 45(3):357-363. PubMed ID: 28162845
[TBL] [Abstract][Full Text] [Related]
9. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
[TBL] [Abstract][Full Text] [Related]
10. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
[TBL] [Abstract][Full Text] [Related]
11. Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model).
Troeltzsch M; Zeiter S; Arens D; Nehrbass D; Probst FA; Liokatis P; Ehrenfeld M; Otto S
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241232
[No Abstract] [Full Text] [Related]
12. Retrospective analysis of bacterial colonization of necrotic bone and antibiotic resistance in 98 patients with medication-related osteonecrosis of the jaw (MRONJ).
Ewald F; Wuesthoff F; Koehnke R; Friedrich RE; Gosau M; Smeets R; Rohde H; Assaf AT
Clin Oral Investig; 2021 May; 25(5):2801-2809. PubMed ID: 33006027
[TBL] [Abstract][Full Text] [Related]
13. Bacterial diversity in medication-related osteonecrosis of the jaw.
Hallmer F; Bjørnland T; Andersson G; Becktor JP; Kristoffersen AK; Enersen M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Apr; 123(4):436-444. PubMed ID: 28159588
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
[TBL] [Abstract][Full Text] [Related]
15. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
16. Further development of the MRONJ minipig large animal model.
Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745
[TBL] [Abstract][Full Text] [Related]
17. Use of Leukocyte- and Platelet-Rich Fibrin in the Treatment of Medication-Related Osteonecrosis of the Jaws.
Maluf G; Caldas RJ; Silva Santos PS
J Oral Maxillofac Surg; 2018 Jan; 76(1):88-96. PubMed ID: 28675810
[TBL] [Abstract][Full Text] [Related]
18. Targeted histological evaluation shows high incidence of actinomyces infection in medication-related osteonecrosis of the jaws.
Brody A; Scheich B; Dobo-Nagy C
Sci Rep; 2022 Mar; 12(1):3406. PubMed ID: 35233034
[TBL] [Abstract][Full Text] [Related]
19. Medication-Related Osteonecrosis of the Jaws in the Pediatric Population.
Neal TW; Schlieve T
J Oral Maxillofac Surg; 2022 Oct; 80(10):1686-1690. PubMed ID: 35931181
[TBL] [Abstract][Full Text] [Related]
20. Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.
Zheng Y; Dong X; Chen S; He Y; An J; Liu M; He L; Zhang Y
BMC Oral Health; 2023 Jan; 23(1):14. PubMed ID: 36627695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
